Hashimoto’s thyroiditis is a disease involving an autoimmune response that many people may have limited awareness of. The disease is characterized by gradual destruction of the thyroid gland over time, and the initial symptoms are often subtle. As the disease progresses, patients may find themselves with painless gland swelling, but may then develop hypothyroidism, which can cause weight gain, fatigue, constipation, hair loss, and other symptoms. Why does the cause of this disease remain such a mystery?
Early stage immune thyroiditis may not show obvious signs during physical examination, and there may not even be any gland swelling.
As the disease progresses, patients may experience varying degrees of thyroid hypertrophy, accompanied by typical symptoms, such as:
Currently, the scientific community still has an incomplete understanding of the causes of Hashimoto’s thyroiditis. It is generally believed that the development of the disease is the result of the interaction between genetic and environmental factors. Studies have shown that about 80% of the risk is related to genetic factors, and 20% is related to environmental factors such as iodine intake, drug effects and stress.
Autoimmune diseases have a clear familial clustering phenomenon, and many patients report a family history of autoimmune diseases.
Diagnosing Hashimoto’s thyroiditis usually involves a combination of testing, including laboratory blood tests, imaging tests, and thyroid function tests. High levels of thyroid stimulating hormone (TSH) and anti-thyroid antibodies (such as TPO antibodies) can help confirm the diagnosis.
In addition to blood tests, ultrasound is often used to evaluate the morphology and structure of the thyroid gland, especially in the presence of antibodies.
In addition to genetic and environmental factors, gender is also a significant influencing factor for Hashimoto’s thyroiditis. The incidence of this disease in women is as high as 17.5%, much higher than the 6% in men. This phenomenon may be related to the immune-related genes on the X chromosome.
Current treatment for Hashimoto’s thyroiditis focuses on controlling concomitant hypothyroidism. Levothyroxine is usually used to supplement the thyroid hormone needed by the body. If the condition is stable, the patient does not need any other treatment. It is also very important to pay attention to proper iodine intake, especially during pregnancy.
ConclusionThe uncertainty of the disease's symptoms and progression means that even professional doctors have difficulty predicting the future course of the disease.
Hashimoto’s thyroiditis remains a global health challenge, with a higher incidence in women. Although our understanding of the causes of this disease is improving, more research is needed to better predict and manage the condition. As the surrounding environment changes and the impact of lifestyle changes, the challenges posed by Hashimoto's may become more complicated. So how can we adjust our lifestyle to reduce the risk of this disease?